Sharing Scientific Information with HCPs on Unapproved Uses

Sharing Scientific Information with HCPs on Unapproved Uses of Medical Products: Dos and Don'ts Under FDA's New Draft Guidance | Epstein Becker & Green

In October 2023, the FDA released draft guidance entitled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared...

Related Keywords

, Health Care Providers Hcps , Epstein Becker , From Firms , Unapproved Uses , Cleared Medical Products , Answers Guidance , Medical Publications , Unapproved New Uses , Reprint Practices , Medical Journal Articles , Scientific Reference Publications , Napproved Drugs , Cleared Medical Devices , Health Care Providers ,